Literature DB >> 30600195

Bone marrow-derived mesenchymal stromal cells ameliorate severe acute pancreatitis in rats via hemeoxygenase-1-mediated anti-oxidant and anti-inflammatory effects.

Zhilong Ma1, Guodong Song2, Dongbo Zhao2, Dalu Liu3, Xiaolei Liu1, Yuxiang Dai1, Zhigang He1, Daohai Qian4, Jian Gong1, Hongbo Meng1, B O Zhou1, Tingsong Yang5, Zhenshun Song6.   

Abstract

BACKGROUND AND AIMS: It has been previously verified that mesenchymal stromal cells (MSCs) have a good therapeutic effect on severe acute pancreatitis (SAP) and the potential for regeneration of damaged pancreatic tissue, but the exact molecular mechanism remains unclear. In this study, we demonstrated the therapeutic effect of bone morrow MSCs (BMSCs) on SAP, probably by targeting heme oxygenase-1 (HO-1).
METHODS: Six hours after SAP induction, either phosphate-buffered saline (PBS) or BMSCs were transfused into the caudal vein of rats, zinc protoporphyrin (ZnPP) was administered intraperitoneally. Pancreatic pathological scoring, serum levels of amylase and inflammatory factors, as well as levels of reactive oxygen species (ROS), malondialdehyde (MDA) and myeloperoxidase (MPO), superoxide dismutase (SOD) and catalase (CAT) activity in the pancreas were evaluated.
RESULTS: Our data showed that BMSCs significantly reduce inflammation and oxidative stress, reduce apoptosis and promote angiogenesis of damaged pancreas. Moreover, BMSCs increased the level of HO-1 in the serum and pancreatic tissue in rats with SAP. In addition, the protective effect of BMSCs was partially neutralized by the HO-1 activity inhibitor ZnPP, suggesting a key role of HO-1 in the therapeutic effect of BMSCs on SAP.
CONCLUSIONS: BMSCs ameliorated SAP, probably by inducing expression of HO-1, which can exert anti-inflammatory and anti-oxidant effects, reduce apoptosis and promote angiogenesis.
Copyright © 2018 International Society for Cell and Gene Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  heme oxygenase-1; inflammatory; mesenchymal stromal cells; oxidative stress; severe acute pancreatitis

Mesh:

Substances:

Year:  2018        PMID: 30600195     DOI: 10.1016/j.jcyt.2018.11.013

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  5 in total

Review 1.  Autophagy: a promising therapeutic target for improving mesenchymal stem cell biological functions.

Authors:  Jiaqiang Deng; Lijun Zhong; Zihan Zhou; Congwei Gu; Xiaoya Huang; Liuhong Shen; Suizhong Cao; Zhihua Ren; Zhicai Zuo; Junliang Deng; Shumin Yu
Journal:  Mol Cell Biochem       Date:  2020-11-16       Impact factor: 3.396

Review 2.  MSCs and Inflammatory Cells Crosstalk in Regenerative Medicine: Concerted Actions for Optimized Resolution Driven by Energy Metabolism.

Authors:  Valerie Planat-Benard; Audrey Varin; Louis Casteilla
Journal:  Front Immunol       Date:  2021-04-30       Impact factor: 7.561

Review 3.  The emerging antioxidant paradigm of mesenchymal stem cell therapy.

Authors:  Rhian Stavely; Kulmira Nurgali
Journal:  Stem Cells Transl Med       Date:  2020-06-04       Impact factor: 6.940

4.  Anti-inflammatory protein TSG-6 secreted by bone marrow mesenchymal stem cells attenuates neuropathic pain by inhibiting the TLR2/MyD88/NF-κB signaling pathway in spinal microglia.

Authors:  Hao Yang; Lingmin Wu; Huimin Deng; Yuanli Chen; Huanping Zhou; Meiyun Liu; Shaochen Wang; Li Zheng; Lina Zhu; Xin Lv
Journal:  J Neuroinflammation       Date:  2020-05-11       Impact factor: 8.322

5.  Long noncoding RNA H19 regulates the therapeutic efficacy of mesenchymal stem cells in rats with severe acute pancreatitis by sponging miR-138-5p and miR-141-3p.

Authors:  Guodong Song; Jia Zhou; Ruimei Song; Dalu Liu; Weidi Yu; Wangcheng Xie; Zhilong Ma; Jian Gong; Hongbo Meng; Tingsong Yang; Zhenshun Song
Journal:  Stem Cell Res Ther       Date:  2020-09-25       Impact factor: 6.832

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.